BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value: $8.48B (100.0% shares, 0.0% debt)

Holdings (6)

— DIVERSEY HLDGS LTD 44.7%

Value $3.791B Shares 236,350,134 Est. Cost $14.71 Unrealized —

SGRY SURGERY PARTNERS INC 24.5%

Value $2.077B Shares 49,064,576 Est. Cost $32.73 Unrealized +55.9%

— CEREVEL THERAPEUTICS HLDNG, INC. 21.1%

Value $1.789B Shares 60,632,356 Est. Cost $16.58 Unrealized —

AVAH AVEANNA HEALTHCARE HLDGS INC 7.7%

Value $650M Shares 81,029,675 Est. Cost $11.86 Unrealized -18.3%

IQV IQVIA HLDGS INC 1.7%

Value $148M Shares 617,484 Est. Cost $101.80 Unrealized +147.9%

ADV ADVANTAGE SOLUTIONS INC 0.3%

Value $25M Shares 2,890,000 Est. Cost $10.52 Unrealized -10.8%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	DIVERSEY HLDGS LTD	236,350,134	$3.791B	44.7%	$14.71	—	ORD SHS	G28923103
SGRY	SURGERY PARTNERS INC	49,064,576	$2.077B	24.5%	$32.73	+55.9%	COM	86881A100
—	CEREVEL THERAPEUTICS HLDNG, INC.	60,632,356	$1.789B	21.1%	$16.58	—	COM	15678U128
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,029,675	$650M	7.7%	$11.86	-18.3%	COM	05356F105
IQV	IQVIA HLDGS INC	617,484	$148M	1.7%	$101.80	+147.9%	COM	46266C105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$25M	0.3%	$10.52	-10.8%	COM CL A	00791N102